Amedisys, Inc. (NASDAQ:AMED) Shares Sold by Legal & General Group Plc

Legal & General Group Plc decreased its position in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 5.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 68,311 shares of the health services provider's stock after selling 3,615 shares during the quarter. Legal & General Group Plc owned 0.21% of Amedisys worth $6,202,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in AMED. Blue Trust Inc. increased its position in shares of Amedisys by 55.1% in the 4th quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock worth $34,000 after purchasing an additional 124 shares during the last quarter. Xponance Inc. lifted its position in shares of Amedisys by 3.5% during the fourth quarter. Xponance Inc. now owns 4,349 shares of the health services provider's stock worth $395,000 after purchasing an additional 148 shares during the last quarter. Inspire Investing LLC grew its stake in Amedisys by 3.6% in the fourth quarter. Inspire Investing LLC now owns 4,405 shares of the health services provider's stock worth $400,000 after purchasing an additional 155 shares in the last quarter. Nisa Investment Advisors LLC increased its holdings in Amedisys by 1.2% in the fourth quarter. Nisa Investment Advisors LLC now owns 15,150 shares of the health services provider's stock valued at $1,375,000 after buying an additional 180 shares during the last quarter. Finally, Retirement Systems of Alabama raised its stake in Amedisys by 0.5% during the fourth quarter. Retirement Systems of Alabama now owns 39,822 shares of the health services provider's stock valued at $3,615,000 after buying an additional 181 shares in the last quarter. Hedge funds and other institutional investors own 94.36% of the company's stock.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on AMED. Stephens reiterated an "equal weight" rating and issued a $101.00 price target on shares of Amedisys in a report on Tuesday, March 4th. Royal Bank of Canada reiterated an "outperform" rating and set a $100.00 target price on shares of Amedisys in a research note on Wednesday, April 16th. Four equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $100.75.

Amedisys Stock Performance

Shares of Amedisys stock traded up $0.10 on Friday, reaching $94.37. 105,069 shares of the company were exchanged, compared to its average volume of 403,974. The firm has a market cap of $3.10 billion, a price-to-earnings ratio of 37.45, a P/E/G ratio of 1.78 and a beta of 0.89. Amedisys, Inc. has a 1-year low of $82.15 and a 1-year high of $98.95. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19. The company's 50-day moving average is $92.17 and its two-hundred day moving average is $91.83.

Amedisys (NASDAQ:AMED - Get Free Report) last issued its earnings results on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share for the quarter, topping the consensus estimate of $1.13 by $0.12. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The firm had revenue of $594.78 million for the quarter, compared to analyst estimates of $597.43 million. As a group, research analysts expect that Amedisys, Inc. will post 4.4 earnings per share for the current fiscal year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.